PSMC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.668000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.687800E-01
Normal-vs-Stage2
2.735400E-01
Normal-vs-Stage3
7.435400E-01
Normal-vs-Stage4
3.210000E-01
Stage1-vs-Stage2
1.603980E-01
Stage1-vs-Stage3
7.602600E-01
Stage1-vs-Stage4
3.559000E-01
Stage2-vs-Stage3
5.690800E-01
Stage2-vs-Stage4
6.338200E-01
Stage3-vs-Stage4
9.527800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.722000E-01
Normal-vs-AfricanAmerican
5.213600E-01
Normal-vs-Asian
2.688600E-01
Caucasian-vs-AfricanAmerican
2.808400E-01
Caucasian-vs-Asian
9.847800E-01
AfricanAmerican-vs-Asian
2.886400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.643600E-01
Normal-vs-Female
2.800200E-01
Male-vs-Female
7.589400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.285200E-01
Normal-vs-Age(41-60Yrs)
9.005600E-02
Normal-vs-Age(61-80Yrs)
4.127200E-01
Normal-vs-Age(81-100Yrs)
8.276200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.640800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.903800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.962600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.796080E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.173400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.328200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.743400E-01
Normal-vs-Daily Drinker
2.283800E-01
Normal-vs-Weekly Drinker
3.357600E-01
Normal-vs-Occasional Drinker
1.020790E-01
Normal-vs-Social Drinker
9.307800E-02
Non Drinker-vs-Daily Drinker
2.356800E-01
Non Drinker-vs-Weekly Drinker
3.429400E-01
Non Drinker-vs-Occasional Drinker
5.730200E-02
Non Drinker-vs-Social Drinker
3.733600E-01
Daily Drinker-vs-Weekly Drinker
9.953600E-01
Daily Drinker-vs-Occasional Drinker
4.146400E-01
Daily Drinker-vs-Social Drinker
6.016000E-01
Weekly Drinker-vs-Occasional Drinker
5.074600E-01
Weekly Drinker-vs-Social Drinker
7.152400E-01
Occasional Drinker-vs-Social Drinker
1.558810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.537200E-01
Normal-vs-Grade 2
9.187600E-01
Normal-vs-Grade 3
9.357400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.618180E-01
Grade 1-vs-Grade 3
1.161980E-01
Grade 1-vs-Grade 4
8.537200E-01
Grade 2-vs-Grade 3
6.623200E-01
Grade 2-vs-Grade 4
9.187600E-01
Grade 3-vs-Grade 4
9.357400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.243400E-01
Normal-vs-NonDiabetic
1.742420E-01
Diabetic-vs-NonDiabetic
4.651400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.457180E-01
Normal-vs-NoPancreatitis
2.632400E-01
Pancreatitis-vs-NoPancreatitis
8.346400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.635600E-01
Normal-vs-N1
2.725200E-01
N0-vs-N1
5.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.103550E-01
Normal-vs-TP53-NonMutant
8.568600E-01
TP53-Mutant-vs-TP53-NonMutant
6.82559999964916E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
